On Tuesday, April 26, a report by the news agency ANI, claimed that the Drugs Controller General of India (DCGI) has accorded restricted emergency use authorisation to Bharat Biotech’s COVID-19 vaccine, Covaxin for children between the age of 6-12 years.
On the other hand, the agency also reported that the DCGI granted emergency use authorisation to Corbevax as well for children between 5-12 years.
#COVID19 | DCGI (Drugs Controller General of India) grants emergency use authorisation to Corbevax for children between the age of 5-12 years: Sources
— ANI (@ANI) April 26, 2022
In addition to this, the narrative claims that the body has also granted emergency use authorisation to ZycovD (Zydus Cadila vaccine) for children over the age of 12 years.
#COVID19 | DCGI grants emergency use authorisation to ZycovD (Zydus Cadila vaccine) for children above the age of 12 years: Sources
— ANI (@ANI) April 26, 2022
(This is a developing story)
